Feasibility of Axillary Reverse Mapping and Clinicopathological Features Predicting ARM Node Metastasis in Breast Cancer—a Pilot Study

被引:11
|
作者
Kumar K.S. [1 ]
Hemanth G.N. [1 ]
Panjwani P.K. [2 ]
Manjunath S. [1 ]
Ramesh R.S. [1 ]
Burrah R. [1 ]
Rout P. [2 ]
Ramu D. [1 ]
Joseph E.P. [1 ]
Chandran R. [1 ]
Prasad C. [1 ]
Goel V. [1 ]
Divya S. [2 ]
机构
[1] Department of Surgical Oncology, St. John’s Medical College Hospital, Sarjapura Road, Bangalore
[2] Department of Pathology, St. John’s Medical College Hospital, Sarjapura Road, Bangalore
关键词
Axillary reverse mapping; Sentinel node;
D O I
10.1007/s13193-016-0578-1
中图分类号
学科分类号
摘要
The axillary reverse mapping (ARM) technique has been described as an attempt to map and preserve the upper extremity lymphatic drainage during axillary lymph node dissection (ALND) and/or SLNB. This technique is based on the hypothesis that the lymphatic pathway from the upper extremity is not involved by metastasis from primary breast cancer. The ARM node/s however, has been found, in various studies, to be involved with metastatic foci in patients with extensive axillary lymph node metastases. Therefore, the oncological safety of this procedure has not yet been determined. In this pilot study, we assessed the ARM node intraoperatively for various parameters and compared it to final HPR, to try and determine the oncologic safety of preserving the ARM node. Seventy-two breast cancer patients were screened for this prospective pilot study which was planned to recruit 20 patients. The study was initiated on May 2014, 20 patients were recruited till July 2015. Eligibility criterion was as follows: patients requiring primary axillary lymph node dissection based on a clinically positive axilla. Forty-five patients were ineligible because they had either received neoadjuvant chemotherapy or underwent previous axillary surgery or axillary radiation (exclusion criteria). Seven patients refused to give consent. ARM node identification rate was 75%. The most common location of the ARM node was lateral to the latissimus dorsi pedicle (42.10%), none of them being malignant. None of the oval or firm nodes were malignant. Tumor deposits were identified in 13%. Fine-needle aspiration cytology (FNAC) had 100% specificity, 94.4% negative predictive value, 100% positive predictive value, and 50% sensitivity. ARM is feasible using blue dye alone, with an acceptable identification rate. Location, consistency, and intraoperative FNAC of the ARM node, put together, may be reliable parameters to predict involvement of the ARM node with metastasis. © 2016, Indian Association of Surgical Oncology.
引用
收藏
页码:119 / 122
页数:3
相关论文
共 50 条
  • [1] Ultrasound and clinicopathological characteristics of breast cancer for predicting axillary lymph node metastasis
    Bai, Xiaofang
    Wang, Yunyue
    Song, Ruxi
    Li, Shangan
    Song, Yan
    Wang, Huan
    Tong, Xiaoning
    Wei, Wei
    Ruan, Litao
    Zhao, Qiaoling
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2023, 85 (02) : 147 - 162
  • [2] Ultrasound Features of Breast Cancer for Predicting Axillary Lymph Node Metastasis
    Guo, Qiang
    Dong, Zhiwu
    Zhang, Lei
    Ning, Chunping
    Li, Ziyao
    Wang, Dongmo
    Liu, Chong
    Zhao, Ming
    Tian, Jiawei
    JOURNAL OF ULTRASOUND IN MEDICINE, 2018, 37 (06) : 1345 - 1353
  • [3] Axillary reverse mapping (ARM) in clinically node positive breast cancer patients
    Beek, M. A.
    Gobardhan, P. D.
    Klompenhouwer, E. G.
    Rutten, H. J. T.
    Voogd, A. C.
    Luiten, E. J. T.
    EJSO, 2015, 41 (01): : 59 - 63
  • [4] Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
    Jiajia Xiong
    Wei Zuo
    Yu Wu
    Xiuhua Wang
    Wenqu Li
    Qiaodan Wang
    Hui Zhou
    Mingxing Xie
    Xiaojuan Qin
    BMC Cancer, 22
  • [5] Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
    Xiong, Jiajia
    Zuo, Wei
    Wu, Yu
    Wang, Xiuhua
    Li, Wenqu
    Wang, Qiaodan
    Zhou, Hui
    Xie, Mingxing
    Qin, Xiaojuan
    BMC CANCER, 2022, 22 (01)
  • [6] Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer
    Noguchi, M.
    Noguchi, M.
    Ohno, Y.
    Morioka, E.
    Nakano, Y.
    Kosaka, T.
    Kurose, N.
    Minato, H.
    EJSO, 2016, 42 (05): : 650 - 656
  • [7] Axillary Reverse Mapping (ARM) to Identify the Sentinel Node of the Upper Limb in Breast Cancer Surgery
    Satish, C.
    Sunny, G.
    Vijaykumar, D. K.
    Sundaram, S.
    CLINICAL ONCOLOGY, 2017, 29 (03) : E77 - E77
  • [8] Utility of Axillary Reverse Mapping (ARM) and Incidence of Metastasis in Arm Draining Lymph Nodes in Patients with Breast Cancer
    Kumar, Pramit
    Singh, Parneet
    Veerwal, Hardik
    Ravi, Bina
    Narayan, Manishi L.
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2022, 21 (01) : 28 - 33
  • [9] Feasibility of Axillary Reverse Mapping During Sentinel Lymph Node Biopsy in Breast Cancer Patients
    Federico Casabona
    Stefano Bogliolo
    Mario Valenzano Menada
    Paolo Sala
    Giuseppe Villa
    Simone Ferrero
    Annals of Surgical Oncology, 2009, 16
  • [10] Feasibility of Axillary Reverse Mapping during Sentinel Lymph Node Biopsy in Breast Cancer.
    Noguchi, M.
    Ohno, Y.
    Nakano, Y.
    Noguchi, M.
    Kosaka, T.
    CANCER RESEARCH, 2011, 71